← Back to Search
Sequential Delivery Of Doxorubicin And Zoledronic Acid To Breast Cancer Cells By CB-Modified Iron Oxide Nanoparticles.
F. Benyettou, M. Alhashimi, M. O'Connor, Renu Pasricha, Jérémy Brandel, H. Traboulsi, Javed Mazher, J. Olsen, A. Trabolsi
Published 2017 · Medicine, Materials Science
Download PDFAnalyze on Scholarcy
Drug-loaded magnetic nanoparticles were synthesized and used for the sequential delivery of the antiresorptive agent zoledronic acid (Zol) and the cytotoxic drug doxorubicin (Dox) to breast cancer cells (MCF-7). Zol was attached to bare iron oxide nanoparticles (IONPs) via phosphonate coordination to form Z-NPs. The unbound imidazole of Zol was then used to complex the organic macrocycle CB to obtain CZ-NPs. Dox was complexed to the CZ-NPs to form the fully loaded particles (DCZ-NPs), which were stable in solution at 37 °C and physiological pH (7.4). Fluorescence spectroscopy established that Dox is released in solution from DCZ-NPs suddenly (i) when the particles are subjected to magnetically induced heating to 42 °C at low pH (5.0) and (ii) in the presence of glutathione (GSH). Mass spectrometry indicated that Zol is released slowly in solution at low pH after Dox release. Magnetic measurements with a magnetic reader revealed that DCZ-NPs are internalized preferentially by MCF-7 cells versus nonmalignant cells (HEK293). Zol and Dox acted synergistically when delivered by the particles. DCZ-NPs caused a decrease in the viability of MCF-7 cells that was greater than the net decrease caused when the drugs were added to the cells individually at concentrations equivalent to those delivered by the particles. MCF-7 cells were treated with DCZ-NPs and subjected to an alternating magnetic field (AMF) which, with the nanoparticles present, raised the temperature of the cells and triggered the intracellular release of Dox, as indicated by fluorescence activated cell sorting (FACS). The cytotoxic effects of the DCZ-NPs on MCF-7 cells were enhanced 10-fold by AMF-induced heating. DCZ-NPs were also able to completely inhibit MCF-7 cell adhesion and invasion in vitro, indicating the potential of the particles to act as antimetastatic agents. Together these results demonstrate that DCZ-NPs warrant development as a system for combined chemo- and thermo-therapeutic treatment of cancer.
This paper references
Apoptosis, Oncosis, and Necrosis
G. Majno (1995)
Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing.
N. Nissen (1998)
The Smart Drug Delivery System and Its Clinical Potential
Dong Liu (2016)
Rationally engineered nanoparticles target multiple myeloma cells, overcome cell-adhesion-mediated drug resistance, and show enhanced efficacy in vivo
T. Kiziltepe (2012)
Synergistic Cisplatin/Doxorubicin Combination Chemotherapy for Multidrug-Resistant Cancer via Polymeric Nanogels Targeting Delivery.
Haiqiu Wu (2017)
Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer
L. Bracci (2014)
Surface Sensitive Fe 2p Photoemission Spectra for alpha-Fe₂O₃ (0001) - The Influence of Symmetry and Crystal-Field Strength
T. Droubay (2001)
Supramolecular Drug‐Delivery Systems Based on Polymeric Core—Shell Architectures.
R. Haag (2004)
Synergistic cytotoxic effects of zoledronic acid and radiation in human prostate cancer and myeloma cell lines.
E. Algur (2005)
Hyperthermia-mediated local drug delivery by a bubble-generating liposomal system for tumor-specific chemotherapy.
Ko-Jie Chen (2014)
Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery.
Challa S. S. R. Kumar (2011)
Enhanced stability and activity of temozolomide in primary glioblastoma multiforme cells with cucurbit[n]uril.
Eric A. Appel (2012)
Differential Effect of Doxorubicin and Zoledronic Acid on Intraosseous versus Extraosseous Breast Tumor Growth In vivo
P. Ottewell (2008)
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.
A. Gupta (2005)
Synthesis of Iron Oxide Nanoparticles Used as MRI Contrast Agents: A Parametric Study.
The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer
R. Coleman (2010)
A fluorescence quenching study of the interaction of Suwannee River fulvic acid with iron oxide nanoparticles.
A. Manciulea (2009)
Symptom management in metastatic breast cancer.
W. Irvin (2011)
Metal-Organic Polyhedron Capped with Cucurbituril Delivers Doxorubicin to Cancer Cells.
Soumen K Samanta (2016)
Sequence‐ and schedule‐dependent enhancement of zoledronic acid induced apoptosis by doxorubicin in breast and prostate cancer cells
H. Neville-Webbe (2005)
Cucurbiturils: from synthesis to high-affinity binding and catalysis.
Khaleel I Assaf (2015)
Multi-drug delivery nanocarriers for combination therapy
Suresh Gadde (2015)
Combined effects of zoledronic acid and doxorubicin on breast cancer cell invasion in vitro
J. Woodward (2005)
Cucurbit[n]uril-capped upconversion nanoparticles as highly emissive scaffolds for energy acceptors.
L. Francés-Soriano (2015)
Cationic supramolecular nanoparticles for co-delivery of gene and anticancer drug.
Q. Hu (2011)
Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.
T. Chou (1984)
Redox-Responsive Viologen-Mediated Self-Assembly of CB-Modified Patchy Particles.
F. Benyettou (2016)
Hybrid superparamagnetic iron oxide nanoparticle-branched polyethylenimine magnetoplexes for gene transfection of vascular endothelial cells.
R. Namgung (2010)
Supramolecular Chemotherapy: Cooperative Enhancement of Antitumor Activity by Combining Controlled Release of Oxaliplatin and Consuming of Spermine by Cucurbituril.
Yueyue Chen (2017)
Apoptosis, oncosis, and necrosis. An overview of cell death.
G. Majno (1995)
Construction of Supramolecular Nanoassembly for Responsive Bacterial Elimination and Effective Bacterial Detection.
Qiaoying Li (2017)
Aggregation-Induced-Emissive Molecule Incorporated into Polymeric Nanoparticulate as FRET Donor for Observing Doxorubicin Delivery.
Xiongqi Han (2015)
Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles.
S. Laurent (2011)
Antitumor effects of doxorubicin followed by zoledronic acid in a mouse model of breast cancer.
P. Ottewell (2008)
Microenvironmental regulation of metastasis
J. Joyce (2009)
Interaction Mechanism of Doxorubicin and SWCNT: Protonation and Diameter Effects on the Drug Loading and Releasing.
Y. Wang (2016)
Drug combination studies and their synergy quantification using the Chou-Talalay method.
T. Chou (2010)
A previously unrecognised hydronium di-cation in the crystal structure of a cucurbituril derivative.
I. Bernal (2005)
Superparamagnetic nanovector with anti-cancer properties: gamma Fe2O3@Zoledronate.
F. Benyettou (2009)
Toward theranostic nanoparticles: CB-functionalized iron oxide for drug delivery and MRI.
F. Benyettou (2013)
A high-throughput mechanofluidic screening platform for investigating tumor cell adhesion during metastasis.
A. Spencer (2016)
Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers
Antibody conjugated magnetic iron oxide nanoparticles for cancer cell separation in fresh whole blood.
Hengyi Xu (2011)
Nanocarrier-mediated co-delivery of chemotherapeutic drugs and gene agents for cancer treatment
L. Kang (2015)
The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles
E. Fröhlich (2012)
Microwave assisted nanoparticle surface functionalization.
F. Benyettou (2011)
Cancer therapy and fluorescence imaging using the active release of doxorubicin from MSPs/Ni-LDH folate targeting nanoparticles.
Dian Li (2013)
Emerging Supramolecular Therapeutic Carriers Based on Host-Guest Interactions.
Anis Abdul Karim (2016)
Cell death mechanisms and their implications in toxicology.
S. Orrenius (2011)
Stimuli Responsive Systems Constructed Using Cucurbit[n]uril-Type Molecular Containers
L. Isaacs (2014)
Viologen-templated arrays of cucurbituril-modified iron-oxide nanoparticles.
F. Benyettou (2015)
Design of Organic
T. Skorjanc (2016)
An introduction to the wound healing assay using live-cell microscopy
J. Jonkman (2014)
Mechanism of host-guest complexation by cucurbituril.
César Marquez (2004)
Selective growth inhibition of cancer cells with doxorubicin-loaded CB-modified iron-oxide nanoparticles
Farah Benyettou (2017)
In vitro evaluation of zoledronic acid resistance developed in MCF-7 cells.
M. Kars (2007)
Influence of the protonation state on the binding mode of methyl orange with cucurbiturils
Suhang He (2016)
Implementation of pharmacokinetic and pharmacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical Research
T. Tuntland (2014)
Supramolecular drug delivery systems : molecular engineering of carrier affinity
Mh Maarten Bakker (2018)
Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects.
Sutapa Barua (2014)
Supramolecular Drug Delivery Systems Based on Water-Soluble Pillar[n]arenes.
Xuan Wu (2016)
Design of Organic Macrocycle-Modified Iron Oxide Nanoparticles for Drug Delivery.
Tina Škorjanc (2017)
Apoptosis, cell adhesion and the extracellular matrix in the three-dimensional growth of multicellular tumor spheroids.
M. Santini (2000)
Superparamagnetic Iron Oxide Nanoparticles: Diagnostic Magnetic Resonance Imaging and Potential Therapeutic Applications in Neurooncology and Central Nervous System Inflammatory Pathologies, a Review
J. Weinstein (2010)
Phosphonic and sulfonic acid-functionalized gold nanoparticles: a solid-state NMR study.
Petr Fiurášek (2007)
Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy.
M. Mahmoudi (2011)
Host–guest complexes of some cucurbit[n]urils with the hydrochloride salts of some imidazole derivatives
Yan Feng (2009)
Thermosensitivity profile of malignant glioma U87-MG cells and human endothelial cells following γ-Fe2O3 NPs internalization and magnetic field application
Amel Hanini (2016)
Size-dependent nonlinear weak-field magnetic behavior of maghemite nanoparticles.
Caroline de Montferrand (2012)
Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy.
P. Parhi (2012)
Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite.
G. H. Nancollas (2006)
Supramolecular ionic liquids based on host–guest cucurbituril imidazolium complexes
Pedro Montes-Navajas (2008)
Mesoporous γ-Iron Oxide Nanoparticles for Magnetically Triggered Release of Doxorubicin and Hyperthermia Treatment.
F. Benyettou (2016)
Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone
P. Ottewell (2009)
Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy
Hsin-I Chang (2012)
Cucurbituril/hydroxyapatite based nanoparticles for potential use in theranostic applications
Sunita Prem Victor (2014)
Cancer Statistics, 2010
A. Jemal (2010)
Bone-Targeted Mesoporous Silica Nanocarrier Anchored by Zoledronate for Cancer Bone Metastasis.
W. Sun (2016)
This paper is referenced by
Cancer Nanomedicine Special Issue Review Anticancer Drug Delivery with Nanoparticles: Extracellular Vesicles or Synthetic Nanobeads as Therapeutic Tools for Conventional Treatment or Immunotherapy
M. Zocchi (2020)
Iron Oxide Nanoparticles for Biomedical Applications: A Perspective on Synthesis, Drugs, Antimicrobial Activity, and Toxicity
L. S. Arias (2018)
Anti‐Tumor Activity of Doxorubicin‐loaded Boehmite Nanocontainers
Carmen Seidl (2019)
A high-loading drug delivery system based on magnetic nanomaterials modified by hyperbranched phenylboronic acid for tumor-targeting treatment with pH response.
Huijia Song (2019)
pH-controlled preferential binding of cucurbituril-coated iron-oxide nanoparticles to 6-mercaptonicotinic acid for fluorescent detection of cadmium ions in the solid state
Reem H. Alzard (2020)
Anti-Tumor Effects of Low Dose Zoledronate on Lung Cancer-Induced Spine Metastasis
Elie Akoury (2019)
3D-Printed Nanoporous Scaffolds Impregnated with Zoledronate for the Treatment of Spinal Bone Metastases
Elie Akoury (2019)
Clustering of Iron Oxide Nanoparticles with Amphiphilic Invertible Polymer Enhances Uptake and Release of Drugs and MRI Properties
Paige M. Price (2019)
Low-dose zoledronate for the treatment of bone metastasis secondary to prostate cancer
Elie Akoury (2019)
Macrocyclic Compounds for Drug and Gene Delivery in Immune-Modulating Therapy
Hongzhen Bai (2019)